Kura Oncology, Inc.
Simbol: KURA
NASDAQ
20.59
USDTržna cena danes
-10.6467
Razmerje P/E
-0.2997
Razmerje PEG
1.57B
Kapaciteta MRK
- 0.00%
Donos DIV
Kura Oncology, Inc. (KURA) Finančni izkazi
Bilanca stanja
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
balance-sheet.row.cash-and-short-term-investments | 1880.65 | 424 | 438 | 518 | ||||||||||||||||
balance-sheet.row.short-term-investments | 1723.96 | 386.6 | 386.2 | 427.3 | ||||||||||||||||
balance-sheet.row.net-receivables | 2.8 | 2.8 | 0 | 0 | ||||||||||||||||
balance-sheet.row.inventory | 0 | 0 | 0 | 0 | ||||||||||||||||
balance-sheet.row.other-current-assets | 32.43 | 5.7 | 8.4 | 4.3 | ||||||||||||||||
balance-sheet.row.total-current-assets | 1907.21 | 432.5 | 446.4 | 522.3 | ||||||||||||||||
balance-sheet.row.property-plant-equipment-net | 31.78 | 8.9 | 6.4 | 8.2 | ||||||||||||||||
balance-sheet.row.goodwill | 0 | 0 | 0 | 0 | ||||||||||||||||
balance-sheet.row.intangible-assets | 0 | 0 | 0 | 0 | ||||||||||||||||
balance-sheet.row.goodwill-and-intangible-assets | 0 | 0 | 0 | 0 | ||||||||||||||||
balance-sheet.row.long-term-investments | 0.61 | 0.2 | 0.2 | 0.2 | ||||||||||||||||
balance-sheet.row.tax-assets | 0 | 0 | 0 | 0 | ||||||||||||||||
balance-sheet.row.other-non-current-assets | 23.08 | 7.4 | 3.3 | 3.3 | ||||||||||||||||
balance-sheet.row.total-non-current-assets | 55.47 | 16.5 | 9.9 | 11.8 | ||||||||||||||||
balance-sheet.row.other-assets | 8.67 | 0 | 0 | 0 | ||||||||||||||||
balance-sheet.row.total-assets | 1971.35 | 448.9 | 456.3 | 534.1 | ||||||||||||||||
balance-sheet.row.account-payables | 6.4 | 2.3 | 1.5 | 3.2 | ||||||||||||||||
balance-sheet.row.short-term-debt | 6.9 | 1.5 | 2.3 | 2.3 | ||||||||||||||||
balance-sheet.row.tax-payables | 0 | 0 | 0 | 0 | ||||||||||||||||
balance-sheet.row.long-term-debt-total | 51.38 | 9.3 | 11.7 | 4.6 | ||||||||||||||||
Deferred Revenue Non Current | 0 | 0 | 0 | 0 | ||||||||||||||||
balance-sheet.row.deferred-tax-liabilities-non-current | 0 | - | - | - | ||||||||||||||||
balance-sheet.row.other-current-liab | 109.76 | 31.5 | 20.2 | 17 | ||||||||||||||||
balance-sheet.row.total-non-current-liabilities | 60.43 | 16.4 | 12 | 5 | ||||||||||||||||
balance-sheet.row.other-liabilities | -23.9 | 0 | 0 | 0 | ||||||||||||||||
balance-sheet.row.capital-lease-obligations | 25.89 | 6.4 | 4.9 | 6.9 | ||||||||||||||||
balance-sheet.row.total-liab | 155.48 | 51.7 | 36 | 27.4 | ||||||||||||||||
balance-sheet.row.preferred-stock | 0 | 0 | 0 | 0 | ||||||||||||||||
balance-sheet.row.common-stock | 0.03 | 0 | 0 | 0 | ||||||||||||||||
balance-sheet.row.retained-earnings | -2811.11 | -721.4 | -568.8 | -433 | ||||||||||||||||
balance-sheet.row.accumulated-other-comprehensive-income-loss | -10.84 | -1.3 | -8 | -1.8 | ||||||||||||||||
balance-sheet.row.other-total-stockholders-equity | 3514.16 | 1120 | 8 | 1.8 | ||||||||||||||||
balance-sheet.row.total-stockholders-equity | 692.24 | 397.3 | -568.8 | -433 | ||||||||||||||||
balance-sheet.row.total-liabilities-and-stockholders-equity | 871.62 | 448.9 | -532.8 | -405.5 | ||||||||||||||||
balance-sheet.row.minority-interest | 0 | 0 | 0 | 0 | ||||||||||||||||
balance-sheet.row.total-equity | 692.24 | 397.3 | -568.8 | -433 | ||||||||||||||||
balance-sheet.row.total-liabilities-and-total-equity | 871.62 | - | - | - | ||||||||||||||||
Total Investments | 1724.16 | 386.8 | 386.2 | 427.3 | ||||||||||||||||
balance-sheet.row.total-debt | 64.64 | 17.2 | 14 | 6.9 | ||||||||||||||||
balance-sheet.row.net-debt | -92.05 | -20.1 | -37.8 | -83.8 |
Izkaz denarnih tokov
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
cash-flows.row.net-income | -168.09 | -152.6 | -135.8 | -130.5 | ||||||||||||||||
cash-flows.row.depreciation-and-amortization | -2.39 | 0.8 | 0.8 | 0.6 | ||||||||||||||||
cash-flows.row.deferred-income-tax | 0 | -19.5 | 0 | 4.6 | ||||||||||||||||
cash-flows.row.stock-based-compensation | 21.24 | 28.1 | 26.3 | 23.6 | ||||||||||||||||
cash-flows.row.change-in-working-capital | 15.09 | 7.8 | -3 | -3.2 | ||||||||||||||||
cash-flows.row.account-receivables | 0 | 0 | 0 | 0 | ||||||||||||||||
cash-flows.row.inventory | 0 | 0 | 0 | 0 | ||||||||||||||||
cash-flows.row.account-payables | 12.56 | 10.3 | -0.8 | -2.5 | ||||||||||||||||
cash-flows.row.other-working-capital | -0.6 | -2.5 | -2.2 | -0.7 | ||||||||||||||||
cash-flows.row.other-non-cash-items | -7.37 | 10.5 | 1.7 | 0.4 | ||||||||||||||||
cash-flows.row.net-cash-provided-by-operating-activities | -137.8 | 0 | 0 | 0 | ||||||||||||||||
cash-flows.row.investments-in-property-plant-an-equipment | -0.22 | -0.2 | -0.6 | -1.1 | ||||||||||||||||
cash-flows.row.acquisitions-net | 0.01 | -15.6 | 0 | 0.1 | ||||||||||||||||
cash-flows.row.purchases-of-investments | -531.05 | -409.8 | -270.7 | -445.7 | ||||||||||||||||
cash-flows.row.sales-maturities-of-investments | 440.36 | 425.5 | 303.9 | 320 | ||||||||||||||||
cash-flows.row.other-investing-activites | -0.01 | 15.6 | 0 | -0.1 | ||||||||||||||||
cash-flows.row.net-cash-used-for-investing-activites | -90.91 | 15.6 | 32.6 | -126.8 | ||||||||||||||||
cash-flows.row.debt-repayment | 0 | 0 | -9.4 | -7.3 | ||||||||||||||||
cash-flows.row.common-stock-issued | 240.6 | 94.8 | 24.7 | 4.4 | ||||||||||||||||
cash-flows.row.common-stock-repurchased | 0 | 0 | 0 | 0 | ||||||||||||||||
cash-flows.row.dividends-paid | 0 | 0 | 0 | 0 | ||||||||||||||||
cash-flows.row.other-financing-activites | 97.43 | 94.8 | 23.3 | -0.6 | ||||||||||||||||
cash-flows.row.net-cash-used-provided-by-financing-activities | 243.15 | 94.8 | 38.6 | -3.4 | ||||||||||||||||
cash-flows.row.effect-of-forex-changes-on-cash | 0 | 0 | 0 | 0 | ||||||||||||||||
cash-flows.row.net-change-in-cash | 14.24 | -14.5 | -38.9 | -234.8 | ||||||||||||||||
cash-flows.row.cash-at-end-of-period | 156.9 | 37.3 | 52 | 90.9 | ||||||||||||||||
cash-flows.row.cash-at-beginning-of-period | 142.66 | 51.8 | 90.9 | 325.7 | ||||||||||||||||
cash-flows.row.operating-cash-flow | -137.8 | -124.8 | -110.1 | -104.6 | ||||||||||||||||
cash-flows.row.capital-expenditure | -0.22 | -0.2 | -0.6 | -1.1 | ||||||||||||||||
cash-flows.row.free-cash-flow | -138.01 | -125 | -110.7 | -105.7 |
Vrstica izkaza poslovnega izida
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
income-statement-row.row.total-revenue | 1.27 | 0 | 0 | 0 | ||||||||||||||||
income-statement-row.row.cost-of-revenue | 0.64 | 0.8 | 0.8 | 0.6 | ||||||||||||||||
income-statement-row.row.gross-profit | 0.63 | -0.8 | -0.8 | -0.6 | ||||||||||||||||
income-statement-row.row.gross-profit-ratio | 0 | 0 | 0 | 0 | ||||||||||||||||
income-statement-row.row.research-development | 126.31 | - | - | - | ||||||||||||||||
income-statement-row.row.selling-general-administrative | 57.38 | - | - | - | ||||||||||||||||
income-statement-row.row.selling-and-marketing-expenses | -0.21 | - | - | - | ||||||||||||||||
income-statement-row.row.other-expenses | -2.5 | 0 | 4 | 0.8 | ||||||||||||||||
income-statement-row.row.operating-expenses | 183.48 | 165 | 139.9 | 131.3 | ||||||||||||||||
income-statement-row.row.cost-and-expenses | 183.69 | 165.8 | 139.9 | 131.3 | ||||||||||||||||
income-statement-row.row.interest-income | 11.86 | 14.7 | 4.3 | 1.2 | ||||||||||||||||
income-statement-row.row.interest-expense | 0.01 | 1.5 | 0.2 | 0.4 | ||||||||||||||||
income-statement-row.row.selling-and-marketing-expenses | -0.21 | - | - | - | ||||||||||||||||
income-statement-row.row.total-other-income-expensenet | 10.68 | 13.2 | 4.8 | 1.4 | ||||||||||||||||
income-statement-row.row.ebitda-ratio-caps | 0 | - | - | - | ||||||||||||||||
income-statement-row.row.other-operating-expenses | -2.5 | 0 | 4 | 0.8 | ||||||||||||||||
income-statement-row.row.total-operating-expenses | 10.68 | 13.2 | 4.8 | 1.4 | ||||||||||||||||
income-statement-row.row.interest-expense | 0.01 | 1.5 | 0.2 | 0.4 | ||||||||||||||||
income-statement-row.row.depreciation-and-amortization | 0.64 | 0.8 | 0.8 | 0.6 | ||||||||||||||||
income-statement-row.row.ebitda-caps | -174.06 | - | - | - | ||||||||||||||||
income-statement-row.row.operating-income | -174.89 | -165.8 | -140.6 | -131.8 | ||||||||||||||||
income-statement-row.row.income-before-tax | -168.09 | -152.6 | -135.8 | -130.5 | ||||||||||||||||
income-statement-row.row.income-tax-expense | 3.07 | 0 | 0.2 | -0.6 | ||||||||||||||||
income-statement-row.row.net-income | -168.09 | -152.6 | -136.1 | -129.9 |
Pogosto zastavljeno vprašanje
Kaj je Kura Oncology, Inc. (KURA) skupna sredstva?
Kura Oncology, Inc. (KURA) skupna sredstva so 448935000.000.
Kakšen je letni prihodek podjetja?
Letni prihodki so 1270000.000.
Kolikšna je stopnja dobička podjetja?
Dobiček podjetja je 0.331.
Kakšen je prosti denarni tok podjetja?
Prosti denarni tok je -1.616.
Kolikšna je neto stopnja dobička podjetja?
Čista stopnja dobička je -117.767.
Kolikšni so skupni prihodki podjetja?
Celotni prihodki so -127.669.
Kaj je Kura Oncology, Inc. (KURA) čisti dobiček (čisti dobiček)?
Čisti dobiček (čisti prihodek) je -152631000.000.
Kolikšen je skupni dolg podjetja?
Skupni dolg je 17200000.000.
Kolikšni so stroški poslovanja?
Stroški poslovanja so 164955000.000.
Kolikšno je število denarnih sredstev podjetja?
Denarna sredstva podjetja so 41506000.000.